Pidilite Industries Q3 Review - Recovery Faster Than Anticipation: Dolat Capital
Range of Fevicol brand products manufactured by Pidilite Industries. (Image: Company website)

Pidilite Industries Q3 Review - Recovery Faster Than Anticipation: Dolat Capital

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dolat Capital Report

Pidilite Industries Ltd.’s Q3 FY21 results were ahead of our estimate as the improvement in business conditions was beyond our anticipation.

The consumer bazaar segment has witnessed strong improvement with up 25.1% growth (up 9.4% increase in Q2 FY21).

Though business-to-business reported a mere 2.7% YoY increase, witnessed significant sequential improvement from a 13% decline in Q2 FY21.

Going ahead, we believe that the company’s strong brand portfolio and wide distribution reach should help accelerate revenue growth.

Click on the attachment to read the full report:

Dolat Capital Pidilite Industries Q3FY21 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.